Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TYMP | P19971 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30513708 | 1.00 | TAAR1 (0.36) | TAAR1KMT2AHTR2CHTR2BHTR6 | |
| SCHEMBL12814948 | 0.84 | TAAR1 (0.39) | TAAR1KMT2AHTR6CYP2A13AR | |
| SCHEMBL3923571 | 0.74 | CALM1 (0.42) | TAAR1LMNAALDH1A1LTA4H | |
| SCHEMBL21494670 | 0.71 | IDO1 (0.34) | TAAR1HTR2CHTR2BHTR6LMNA | |
| SCHEMBL21494748 | 0.70 | HPGD (0.48) | TAAR1HTR2CHTR2BLMNAALDH1A1 | |
| SCHEMBL30513710 | 0.70 | HPGD (0.48) | TAAR1HTR2CHTR2BLMNAALDH1A1 | |
| SCHEMBL12815284 | 0.70 | ESR1 (0.36) | — | |
| SCHEMBL30513712 | 0.70 | CALM1 (0.35) | KMT2ALTA4H | |
| SCHEMBL21494763 | 0.70 | CALM1 (0.35) | KMT2ALTA4H | |
| SCHEMBL21494751 | 0.70 | DAO (0.41) | TAAR1KMT2AHTR2CHTR2BHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138121-A1 | SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS | CHEVRON U S A INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12269018-B2 | Platinum-sulfur-based shell catalyst, production and use thereof in the dehydrogenation of hydrocarbons | CLARIANT INTERNATIONAL LTD (CH) | 2025-04-08 | — | — | US | disclosed |
| US-20250065311-A1 | SULFIDATED NOBLE METAL ON METAL DOPED SUPPORT AS A HYDROGENATION AND DEHYDROGENATION CATALYST | CHEVRON USA INC (US) | 2025-02-27 | — | — | US | disclosed |
| CN-111989156-B | Shell catalyst based on platinum-sulphur, production and use in hydrocarbon dehydrogenation | 科莱恩国际有限公司 | 2023-08-11 | — | — | CN | disclosed |
| US-20210077984-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | CLARIANT INTERNATIONAL LTD (CH) | 2021-03-18 | — | — | US | disclosed |
| EP-3781307-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | Clariant International Ltd (CH) | 2021-02-24 | — | — | EP | disclosed |
| CN-111989156-A | Platinum-sulfur based shell catalysts, their production and use in the dehydrogenation of hydrocarbons | 科莱恩国际有限公司 | 2020-11-24 | — | — | CN | disclosed |
| WO-2019201706-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | CLARIANT INTERNATIONAL LTD (CH) | 2019-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138121-A1 | SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS | NUDC, SOD1, TIMM10 | TAAR1 4199/4885KMT2A 1280/4885HTR2C 778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.